N-methyl-d-aspartate receptor: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett |
mNo edit summary |
||
Line 15: | Line 15: | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] |
Latest revision as of 11:00, 22 September 2024
The N-methyl-d-aspartate receptor (NMDA receptor) is the binding site for glutamate, n-methyl-d-aspartate and glycine.[1] NMDA receptors are ionotropic as they allow calcium and sodium ions to flow into the cell while potassium ions leave. This excitatory change hypopolarizes the cell and makes it more likely to fire.
NMDA receptors are implicated in memory and learning through the process of long-term potentiation.
Pharmacology
NMDA receptor inhibitors
NMDA receptor antagonists include ketamine, memantine, dextromethorphan, methadone, and MK-801.
NMDA receptor inhibitors may help treat dementia[2] and tolerance to opioid analgesics[3].
References
- ↑ Anonymous (2024), N-methyl-d-aspartate receptor (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Ellul J, Archer N, Foy CM, et al (March 2007). "The effects of commonly prescribed drugs in patients with Alzheimer's disease on the rate of deterioration". J. Neurol. Neurosurg. Psychiatr. 78 (3): 233–9. DOI:10.1136/jnnp.2006.104034. PMID 17012333. Research Blogging.
- ↑ Prommer E (2006). "Rotating methadone to other opioids: a lesson in the mechanisms of opioid tolerance and opioid-induced pain.". J Palliat Med 9 (2): 488-93. DOI:10.1089/jpm.2006.9.488. PMID 16629581. Research Blogging.